Ratan Lab
News & Impact

You are here

Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.

PUBLICATION: 
Journal Article
Authors: 
Siddiq A, Aminova LR, Troy CM, Suh K, Messer Z, Semenza GL, Ratan RR.
Year Published: 
2009
Publisher: 
J Neurosci. 2009 Jul 8;29(27):8828-38. doi: 10.1523/JNEUROSCI.1779-09.2009.
Identifiers: 
PMID:19587290 | PMCID:PMC3290095
Full-Text on PubMed

Associated

Conditions & Recovery

Stroke icon
Stroke is the leading cause of disability in the U.S.
Spinal Cord Injury icon
Around the world, between 300,000 and 500,000 people are living with a SCI.
Neurodegenerative Diseases icon
Worldwide, 50 million people are living with Alzheimer's and other dementias.

Research Methods